Kritische Herzfehler des Neugeborenen

Einleitung

In diesem Übersichtsartikel werden neben den pathophysiologischen Grundlagen die wichtigsten kritischen Herzfehler der Neonatalperiode, deren adäquate Versorgung im Kreißsaal sowie die möglichen konventionellen, interventionellen oder operativen Therapieoptionen dargestellt. Im Besonderen werden auch die klinischen Symptome kritischer angeborener Herzfehler und die für die Erstversorgenden entscheidenden Therapiekonzepte zur Stabilisierung des Neugeborenen präsentiert. Der Artikel gliedert sich in 2 Teile: Im ersten Teil in dieser Ausgabe werden diagnoseübergreifend Pathophysiologie, Diagnostik und Grundlagen der Behandlung kritischer Herzfehler des Neugeborenen dargestellt. Im zweiten Teil des Artikels, den Sie in einer der nächsten Ausgaben lesen können, liegt der Schwerpunkt auf der Darstellung spezieller ausgewählter kritischer Herzfehler des Neugeborenen, deren pathophysiologischen Besonderheiten, der Diagnostik, dem initialen Management und möglichen Therapieoptionen.

• Literatur

• 1 Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 2010; 222: 321-326
• 2 Wren C, Irving CA, Griffiths JA et al. Mortality in infants with cardiovascular malformations. Eur J Pediatr 2012; 171: 281-287
• 3 Meberg A, Lindberg H, Thaulow E. Congenital heart defects: the patients who die. Acta Paediatr 2005; 94: 1060-1065
• 4 Wren C, Reinhardt Z, Khawaja K. Twenty-year trends in diagnosis of life-threatening neonatal cardiovascular malformations. Arch Dis Child Fetal Neonatal Ed 2008; 93: F33-F35
• 5 Schultz AH, Localio AR, Clark BJ et al. Epidemiologic features of the presentation of critical congenital heart disease: implications for screening. Pediatrics 2008; 12: 751-757
• 6 Mellander M, Sunnegardh J. Failure to diagnose critical heart malformations in newborns before discharge – an increasing problem. Acta Paediatr 2006; 95: 407-413
• 7 Acharya G, Sitras V, Maltau JM et al. Major congenital heart disease in Northern Norway: shortcomings of pre- and postnatal diagnosis. Acta Obstet Gynecol Scand 2004; 83: 1124-1129
• 8 Mellander M. Diagnosis and management of life-threatening cardiac malformations in the newborn. Semin Fetal Neonat M 2013; 18: 302-310
• 9 Fixler DE, Xu P, Nembhard WN et al. Age at referral and mortality from critical congenital heart disease. Pediatrics 2014; 134: e98-e105
• 10 Peterson C, Dawson A, Grosse SD et al. Hospitalizations, costs, and mortality among infants with critical congenital heart disease: how important is timely detection. Birth Defects Res Part A-Clin Mol Teratol 2013; 97: 664-672
• 11 Bonnet D, Coltri A, Butera G et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999; 99: 916-918
• 12 Tworetzky W, McElhinney DB, Reddy VM et al. Improved surgical outcome after fetal diagnosis of hypoplastic left heart syndrome. Circulation 2001; 103: 1269-1273
• 13 Rudolph AM. Congenital Diseases of the Heart: clinical-physiological considerations. 3rd ed. Wiley-Blackwell; 2009
• 14 Lakshminrusimha S. The pulmonary circulation in neonatal respiratory failure. Clin Perinatol 2012; 39: 655-683
• 15 Rudolph AM. Congenital cardiovascular malformations and the fetal circulation. Arch Dis Child Fetal Neonatal Ed 2010; 95: F132-F136
• 16 Cernada M, Cubells E, Torres-Cuevas I et al. Oxygen in the delivery room. Early Hum Dev 2013; 89: 11-13
• 17 Miller SP, McQuillen PS, Hamrick S et al. Abnormal brain development in newborns with congenital heart disease. N Engl J Med 2007; 357: 1928-1938
• 18 Shedeed SA, Elfaytouri E. Brain maturity and brain injury in newborns with cyanotic congenital heart disease. Pediatr Cardiol 2011; 32: 47-54
• 19 Franke J, Haas NA. Deutsche Gesellschaft für pädiatrische Kardiologie. S2-Leitlinie: Abklärung einer Zyanose. 2011
• 20 Chaoui R, Heling K, Mielke G et al. Quality standards of the DEGUM for performance of fetal echocardiography. Ultraschall in Med 2008; 29: 197-200
• 21 Rychik J, Ayres N, Cuneo B et al. American Society of Echocardiography guidelines and standards for performance of the fetal echocardiogram. Journal of the American Society of Echocardiography: official publication of the American Society of Echocardiography 2004; 17: 803-810
• 22 Bull C. British Paediatric Cardiac Association. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. Lancet 1999; 354: 1242-1247
• 23 Mahle WT, Newburger JW, Matherne GP et al. Role of pulse oxymetry in examining newborns for congenital heart disease: a scientific statement from the American Heart Association and American Academy of Pediatrics. Circulation 2009; 120: 447-458
• 24 Riede FT, Dahnert I, Schneider P et al. Pulse oxymetry screening at 4 hours of age to detect critical congenital heart defects. Pediatrics 2009; 123: e542;-e543 author reply e542
• 25 de-Wahl GranelliA, Wennergren M, Sandberg K et al. Impact of pulse oxymetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ Clin Res Ed 2009; 338: a3037
• 26 Valmari P. Should pulse oxymetry be used to screen for congenital heart disease. Arch Dis Child Fetal Neonatal Ed 2007; 92: F219-F224
• 27 Herting E, Vetter K, Gonser M et al. Betreuung von gesunden reifen Neugeborenen in der Geburtsklinik. AWMF-Leitlinie 2012; 024/005
• 28 Mahle WT, Martin GR, Beekman 3rd RH et al. Endorsement of Health and Human Services recommendation for pulse oxymetry screening for critical congenital heart disease. Pediatrics 2012; 129: 190-192
• 29 Elsasser S. Zyanose. Schweiz Med Forum 2003; 19: 447-454
• 30 Koeditz H. Kardiologische/kardiochirurgische Intensivmedizin. In: Kretz F-J, Beushausen T, Ure BM, Roth B, Hrsg. Kinder Notfall-Intensiv. München: Elsevier; 2010: 295-309
• 31 Marino BS, Bird GL, Wernovsky G. Diagnosis and management of the newborn with suspected congenital heart disease. Clin Perinatol 2001; 28: 91-136
• 32 Perlman JM, Wyllie J, Kattwinkel J et al. Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation 2010; 122: 516-538
• 33 Huang FK, Lin CC, Huang TC et al. Reappraisal of the prostaglandin E1 dose for early newborns with patent ductus arteriosus-dependent pulmonary circulation. Pediatr Neonatol 2013; 54: 102-106
• 34 da Cruz EM, Dunbar I, Jaggers J (Eds.) Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care. London: Springer; 2014
• 35 Lewis AB, Freed MD, Heymann MA et al. Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease. Circulation 1981; 64: 893-898
• 36 Brooks PA, Penny DJ. Management of the sick neonate with suspected heart disease. Early Hum Dev 2008; 84: 155-159